News story

Animal medicines improvement notice: CV Pharma Ltd

Details of the improvement notice issued to CV Pharma Ltd, Godalming, Surrey. Published in June 2016.

This news article was withdrawn on

Withdrawn as over a year old

VMD Lecturn

CV247, an unauthorised medicine containing sodium salicylate, is being presented to UK customers for use in treating cancer in animals. This is in breach of the Veterinary Medicines Regulations.

Measures to be taken are:

  1. All references to using CV247 within the UK for treating animals with cancer must be removed from all publically available material published by or on behalf of CV Pharma Ltd.
  2. All reference to using CV247 in animals must be removed from all digital material published by or on behalf of CV Pharma Ltd , including CV Therapy .com and CV Pharma Ltd social media outlets.

This notice has been complied with

Published 7 June 2016
Last updated 28 June 2016 + show all updates
  1. This notice has been complied with
  2. First published.